363 related articles for article (PubMed ID: 29753318)
1. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
[TBL] [Abstract][Full Text] [Related]
2. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy in a woman with maple syrup urine disease.
Grünewald S; Hinrichs F; Wendel U
J Inherit Metab Dis; 1998 Apr; 21(2):89-94. PubMed ID: 9584259
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
[TBL] [Abstract][Full Text] [Related]
6. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
[TBL] [Abstract][Full Text] [Related]
7. Successful Pregnancy in a Woman with Maple Syrup Urine Disease: Case Report.
Heiber S; Zulewski H; Zaugg M; Kiss C; Baumgartner M
JIMD Rep; 2015; 21():103-7. PubMed ID: 25720565
[TBL] [Abstract][Full Text] [Related]
8. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
Thompson GN; Francis DE; Halliday D
J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.
Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM
Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241
[TBL] [Abstract][Full Text] [Related]
11. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
12. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study.
Kaur J; Nagy L; Wan B; Saleh H; Schulze A; Raiman J; Inbar-Feigenberg M
Clin Chim Acta; 2020 Jan; 500():195-201. PubMed ID: 31678570
[TBL] [Abstract][Full Text] [Related]
13. Living related versus deceased donor liver transplantation for maple syrup urine disease.
Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
[TBL] [Abstract][Full Text] [Related]
14. Classical maple syrup urine disease and brain development: principles of management and formula design.
Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH
Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171
[TBL] [Abstract][Full Text] [Related]
15. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease.
Simon E; Fingerhut R; Baumkötter J; Konstantopoulou V; Ratschmann R; Wendel U
J Inherit Metab Dis; 2006 Aug; 29(4):532-7. PubMed ID: 16817013
[TBL] [Abstract][Full Text] [Related]
16. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
18. Implications of Maple Syrup Urine Disease in Newborns.
Harris-Haman P; Brown L; Massey S; Ramamoorthy S
Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
[TBL] [Abstract][Full Text] [Related]
19. Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease.
Mitsubuchi H; Owada M; Endo F
J Nutr; 2005 Jun; 135(6 Suppl):1565S-70S. PubMed ID: 15930470
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]